1. Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

   • Jame Abraham
   • Humberto Caldera
   • Chuck Vogel

   Review Open access 19 January 2018 Pages: 1 - 7

2. Is invasion a necessary step for metastases in breast cancer?

   • Steven A. Narod
   • Victoria Sopik

   Review Open access 20 January 2018 Pages: 9 - 23

   

3. GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer

   • Yun-Bi Ni
   • Julia Y. S. Tsang
   • Gary M. Tse

   Preclinical study 16 January 2018 Pages: 25 - 32

4. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement

   • Timco Koopman
   • Henk J. Buikema
   • Bert van der Vegt

   Preclinical study Open access 18 January 2018 Pages: 33 - 42

   

5. Impact of an embedded genetic counselor on breast cancer treatment

   • Holly J. Pederson
   • Najaah Hussain
   • Stephen R. Grobmyer

   Preclinical study 18 January 2018 Pages: 43 - 46

6. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ

   • Virginie Ory
   • William B. Kietzman
   • Anna T. Riegel

   Preclinical study 19 January 2018 Pages: 47 - 57

   

7. Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients

   • Zhenhua Fan
   • Tao Ouyang
   • Yuntao Xie

   Preclinical study 22 January 2018 Pages: 59 - 67

   

8. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer

   • Jie Cheng
   • Tim Holland-Letz
   • Barbara Burwinkel

   Clinical trial 16 January 2018 Pages: 69 - 82

   

9. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis

   • Elisa García Garre
   • Ginés Luengo Gil
   • Francisco Ayala de la Peña

   Clinical trial 16 January 2018 Pages: 83 - 92

   

10. Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial

    • Sara Mijwel
    • Malin Backman
    • Helene Rundqvist

    Clinical trial Open access 18 January 2018 Pages: 93 - 103

    

11. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

    • Florentia Fostira
    • Emmanouil Saloustros
    • Irene Konstantopoulou

    Epidemiology 15 January 2018 Pages: 105 - 113

    

12. Associations of coffee consumption and caffeine intake with mammographic breast density

    • Lusine Yaghjyan
    • Graham Colditz
    • Rulla M. Tamimi

    Epidemiology 17 January 2018 Pages: 115 - 123

13. Assessment of potential risk factors for breast cancer in a population in Southern Brazil

    • Juliana Zeni Breyer
    • Eliana Marcia Wendland
    • Luciano Serpa Hammes

    Epidemiology 17 January 2018 Pages: 125 - 131

14. Living with chronic pain: perceptions of breast cancer survivors

    • Ting Bao
    • Andrew Seidman
    • Jun J. Mao

    Epidemiology 19 January 2018 Pages: 133 - 140

    

15. Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry

    • Tarsha Jones
    • Debra Duquette
    • Maria C. Katapodi

    Epidemiology 20 January 2018 Pages: 141 - 152

    

16. Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence

    • Charlotte Pourcelot
    • Emeline Orillard
    • Virginie Nerich

    Epidemiology 23 January 2018 Pages: 153 - 162

    

17. Trajectories of quality of life following breast cancer diagnosis

    • Neha G. Goyal
    • Beverly J. Levine
    • Nancy E. Avis

    Epidemiology 24 January 2018 Pages: 163 - 173

    

18. Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative

    • Lu Zhang
    • Qingzhao Yu
    • Tekeda Ferguson

    Epidemiology 24 January 2018 Pages: 175 - 187

    

19. Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience

    • Krishan R. Jethwa
    • Mohamed M. Kahila
    • Robert W. Mutter

    Brief Report 18 January 2018 Pages: 189 - 196

    

20. Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience

    • Nafisha Lalani
    • Karen M. Winkfield
    • Rachel B. Jimenez

    Brief Report 22 January 2018 Pages: 197 - 202

    

21. Detailed information about chemotherapy in breast control arm might affect cognitive sequelae compared with endocrine therapy patients

    • Kadri Altundag

    Letter to the Editor 20 January 2018 Pages: 203 - 203

22. Reply to K. Altundag

    • E. A. Underwood
    • M. C. Tierney

    Rebuttal Letter 06 February 2018 Pages: 205 - 205